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Introduction {#sec1}
============

Bacteria residing in natural communities maintain intricate molecular crosstalk with proximal prokaryotic and eukaryotic cells. Dedicated machineries such as type III, IV, and VI secretion systems are used by bacteria to conduct contact-dependent molecular delivery among species, as well as across kingdoms ([@bib8], [@bib21]). We have previously described a type of bacterial contact-dependent interaction mediated by membranous conduits, termed nanotubes, bridging neighboring cells of the bacterium *Bacillus subtilis* (*Bs*) ([@bib13], [@bib14]). In fact, nanotube-like structures were shown to be produced by multiple bacterial species, mainly when grown on solid surfaces or in biofilm assemblies (e.g., [@bib29], [@bib36], [@bib46]); however, their function remains mostly elusive. Our previous analysis revealed that nanotubes serve as conduits for an intercellular exchange of cytoplasmic proteins and even plasmids ([@bib4], [@bib13], [@bib14], [@bib41]). Furthermore, we and others reported that nanotubes facilitate interspecies molecular trafficking, including that of nutrients and toxins ([@bib6], [@bib36], [@bib41]).

Inspired by these results, we recently discovered that enteropathogenic *E. coli* (EPEC) uses nanotubes to interact with infected epithelial cells ([@bib34]). The formation of these nanotubes was dependent on five inner membrane proteins, composing the export apparatus of the type III secretion system (T3SS), embedded within the injectisome, the major virulence machinery of EPEC ([@bib34]). The Gram-positive *Bs* lacks injectisome, which is restricted to Gram-negative pathogens, but its flagellum harbors integral T3SS, including an export apparatus ([@bib1], [@bib10], [@bib11]). We thus hypothesized that the *Bs* flagellar export apparatus, termed here CORE (CORE-F~Bs~), is required not only for motility ([@bib23]) but also for nanotube generation. The CORE, situated at the basal body of the flagella, is composed of five channel-forming integral membrane proteins, FliP, FliQ, FliR, FlhB, and FlhA, exhibiting a stoichiometry of 5:4:1:1:9, respectively ([@bib12], [@bib16], [@bib26]) ([Figure 1](#fig1){ref-type="fig"}A). In addition, FliO, a non-structural component of the CORE, serves as a scaffold for the assembly of FliP multimeric ring, the presumed nucleation step of the CORE complex assembly ([@bib15], [@bib16]).Figure 1*Bs CORE* Mutants Are Impaired in Nanotube Formation(A) Schematic illustration of the flagellar CORE apparatus on the basis of [@bib16] and [@bib26]. The CORE consists of FliP, FliQ, FliR, FlhB, and FlhA (5:4:1:1:9) transmembrane proteins and the chaperone FliO (not shown), which only transiently associates with the CORE complex.(B) A map depicting the *fla*/*che* operon of *Bs*, encoding the components required for flagellar basal body formation. Genes encoding the CORE proteins are highlighted with the same color code as in (A).(C) The indicated *Bs CORE* mutant strains were visualized using XHR-SEM to monitor the formation of intercellular nanotubes. Strains were grown to the mid-logarithmic phase, spotted onto EM grids, incubated on LB agar plates for 4 h at 37°C, and visualized using XHR-SEM. Scale bar represents 500 nm.(D) Quantification of the average number of nanotubes displayed per 50 cells by the indicated *Bs* mutant strains following XHR-SEM analysis described in (C). Shown are average values and SD of at least three independent experiments (n ≥ 200 for each strain).See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Here we describe that the CORE complex, the central constituent of the bacterial flagellum, has a dual utility, serving as a platform for both flagellum and nanotube biogenesis. We reveal that the CORE is positioned at sites of nanotube emergence, enabling their production along with the associated intercellular molecular exchange. Subsequently, by using bioinformatics and functional analyses, we show that the sequence and utility of CORE components are conserved among distinct bacterial species. Taken together, our results expose the existence of a bacterial organelle related to flagella and injectisome that is likely to provide a major and prevalent route for intercellular molecular exchange in bacteria.

Results {#sec2}
=======

Flagellar CORE Proteins Are Required for Nanotube Formation {#sec2.1}
-----------------------------------------------------------

To investigate whether CORE-F~Bs~ is required for nanotube formation, we generated a non-polar deletion of a chromosomal fragment, containing the five *CORE* genes *fliP*, *fliQ*, *fliR*, *flhB*, and *flhA,* as well as *fliO*, encoding the CORE-associated chaperone (*ΔCORE*) ([Figures 1](#fig1){ref-type="fig"}A and 1B) ([@bib15], [@bib16]). We then used extreme-high-resolution scanning electron microscopy (XHR-SEM) to examine the capacity of this mutant to form nanotubes on a solid surface, conditions restricting flagella formation and facilitating nanotube biogenesis ([@bib13]). Remarkably, the *ΔCORE* mutant exhibited severe deficiency in the formation of intercellular nanotubes ([Figures 1](#fig1){ref-type="fig"}Ca, 1Cb, and 1D). Consistently, the mutant was blocked in generating extending nanotubes ([Figure S1](#mmc1){ref-type="supplementary-material"}A), shown to be produced at low cell density ([@bib14]). Ectopic complementation of the mutant with *CORE* genes restored nanotube formation to that of wild-type levels ([Figures 1](#fig1){ref-type="fig"}Cc and 1D). Importantly, nanotube structures were readily evident in bacteria deleted of genes encoding non-*CORE* key flagellar components. These include mutants lacking *hag*, encoding flagellin; *flgB*, *flgC*, *fliE*, and *fliF* (*ΔflgB*--*fliF*), encoding non-*CORE* basal body components; and *fliI*, encoding the flagellar ATPase, a key component of the CORE-associated sorting platform ([Figures 1](#fig1){ref-type="fig"}B, 1Cj, 1D, and [S1](#mmc1){ref-type="supplementary-material"}B) ([@bib31]). These results indicate that the defect observed in nanotube production can be directly attributed to the function of the *CORE*, suggesting a dual function for this complex in biogenesis of either flagella or nanotubes.

To elucidate whether all six *CORE* genes are required for nanotube projection, we deleted each gene individually. Strains lacking *fliO*, *fliP*, *fliQ*, or *flhA* were severely deficient in nanotube construction, whereas *flhB* mutant could seldom form nanotubes, but these were very slim and frequently torn apart ([Figures 1](#fig1){ref-type="fig"}Cd--1Ci and 1D). Interestingly, *fliR* mutant generated very short projections, exhibiting a bristle-like shape ([Figure 1](#fig1){ref-type="fig"}Cg), suggesting that nanotube formation was initiated but their elongation process was halted. Reintroducing each *CORE* gene into the corresponding *CORE* mutant restored nanotube development ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). Thus, all CORE components are required for production of proper nanotubes, though lack of each component affects the process with slight variations, highlighting further complexity layer in nanotube generation.

CORE-F~Bs~ Is Required for Intercellular Molecular Trade {#sec2.2}
--------------------------------------------------------

Having established that the *CORE* genes are required for nanotube development, we next sought to explore their influence on intercellular molecular exchange. Previously, we found that mixing two strains, each harboring a different antibiotic resistance gene, results in the exchange of antibiotic resistance enzymes in a nanotube-dependent path, yielding a population of cells transiently resistant to both antibiotics (protein exchange). Furthermore, in a similar manner, we detected the delivery of a non-conjugative plasmid from donor to recipient (plasmid exchange) ([@bib13]). Indeed, a *Bs* mutant lacking the *CORE* genes was severely deficient in both protein and plasmid exchange ([Figure 2](#fig2){ref-type="fig"}). Consistently, both defects were cured by reintroducing the *CORE* genes into the mutant strain ([Figure 2](#fig2){ref-type="fig"}). Analyzing the *CORE* single mutants revealed that they were all significantly impaired in protein exchange, with Δ*flhA* and Δ*flhB* showing the most severe phenotype, whereas *fliR* mutant, harboring the bristle-like nanotubes, was the least affected ([Figures 1](#fig1){ref-type="fig"}Cg and [2](#fig2){ref-type="fig"}). Moreover, each and every single mutant was fully defective in plasmid exchange ([Figure 2](#fig2){ref-type="fig"}), indicating that such event exemplifies a more challenging task than protein trade. Importantly, none of the *CORE* mutants exhibited any measurable growth defect ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). The capacity to exchange proteins and plasmids was regained by complementing the individual *CORE* mutants with the corresponding *CORE* gene ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Mutants lacking non-*CORE* flagellum genes (*flgB*--*fliF*, *fliI*, and *hag*) were capable of performing molecular exchange, while their motility was fully blocked ([Figure 2](#fig2){ref-type="fig"}). Notably, Δ*flgB*--*fliF* and Δ*fliI* strains exhibited minor deficiency in both protein and plasmid exchange that is consistent with the modestly reduced number of nanotube structures detected ([Figures 1](#fig1){ref-type="fig"}D and [2](#fig2){ref-type="fig"}). Because the expression of *CORE* genes was not perturbed by these mutations ([Figure S1](#mmc1){ref-type="supplementary-material"}G), this effect might imply some role of these proteins in stabilizing the CORE complex. Overall, our results strengthen the view that the CORE-F~Bs~ mediates intercellular molecular trafficking via nanotubes.Figure 2*Bs CORE* Mutants Are Deficient in Molecular ExchangeAssessing molecular exchange in *CORE* mutants. For protein exchange assay, pairs of a donor (SB463: *amyE*::P~*hyper-spank*~-*cat*-*spec*) (Cm^R^, Spec^R^) and a recipient (SB513: *amyE*::P~*hyper-spank*~-*gfp-kan*) (Kan^R^) parental strains (wild-type) were used. The investigated mutants harbor the corresponding genotypes and carry the indicated null mutation in both donor and recipient strains. Donor and recipient strains were mixed in 1:1 ratio (at two concentrations, 1× and 0.1×) and incubated in LB supplemented with 1 mM IPTG for 4 h at 37°C with gentle shaking. Equal numbers of cells were then spotted onto LB agar (control) and LB agar containing chloramphenicol (Cm) and kanamycin (Kan) (protein exchange) and photographed after 18 h. For plasmid exchange assay, pairs of a donor (GD110: *amyE*::P~*hyper-spank*~-*cat-spec*, pHB201/*cat*, *erm*) (Cm^R^, Spec^R^, Mls^R^) and a recipient (SB513: *amyE*::P~*hyper-spank*~-*gfp-kan*) (Kan^R^) parental strains (wild-type) were used, with the investigated mutants harbor in addition the indicated null mutation in both donor and recipient strains. Cells were mixed in 1:1 ratio (concentration 1×), processed as described for protein exchange, and spotted onto LB agar containing Cm, Kan, and lincomycin (Lin) (plasmid exchange). Cells were incubated at 37°C, and colonies were photographed after 36 h of incubation. For motility assay, wild-type (PY79) and the indicated mutant strains were grown to the mid-logarithmic phase and spotted onto LB plates containing 0.3% agar and photographed after 7 h of incubation at 37°C (motility). See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Next, we examined the impact of CORE on nanotube-dependent interspecies interactions. We have previously shown that *Bs* kills neighboring *B. megaterium* (*Bm*) cells by delivering the tRNase toxin WapA via nanotubes ([@bib41]). GFP-labeled *Bs* was mixed with *Bm*, and cells were visualized using time-lapse microscopy. *Bs* cells, lacking *CORE*, indeed failed to arrest *Bm* growth and division, inferring that the transfer of WapA toxin into *Bm* cells was impeded ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Consistently, ectopic expression of *CORE* genes restored this capability ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Thus, interspecies delivery of WapA via nanotubes is CORE dependent.

CORE Components Are Localized to the Site of Nanotube Emergence {#sec2.3}
---------------------------------------------------------------

Since the CORE complex is a prime constituent of the flagellar basal body ([@bib11]), we posited that in a similar fashion, the CORE forms a platform from which nanotubes emerge and extend. The major CORE component FlhA, harboring a large cytoplasmic domain ([Figure 1](#fig1){ref-type="fig"}A) ([@bib32]), was fused to GFP. The fusion rendered the protein partially functional ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C); however, the few nanotubes produced by these cells emerged from sites adjacent to FlhA-GFP focal assemblies ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E), hinting that nanotubes are projected from CORE-containing complexes. To further establish this notion, we co-visualized nanotubes and CORE components at high resolution by using immuno-XHR-SEM. To this end, FliP was HA-tagged in its C terminus, predicted to be exposed at the cell surface ([@bib16]) ([Figure 1](#fig1){ref-type="fig"}A), and introduced into the *Bs* genome ectopically. Next, cells were subjected to immuno-XHR-SEM, using primary anti-HA antibody followed by gold-labeled secondary antibodies. Strikingly, a gold particle was recurrently observed at the site of nanotube emanation, signifying that indeed the CORE serves as the basal body for nanotube construction ([Figures 3](#fig3){ref-type="fig"}A and 3B). Consistently, signal from FliP was also detected at the origin of extending nanotubes ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Tagging FliP at a site predicted to form a surface-exposed loop ([@bib16]) showed a similar outcome ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Furthermore, use of a mutant (*Δmbl*) exhibiting a defect in cell wall assembly ([@bib24]) to improve antibody accessibility to CORE complexes, or a strain harboring tagged *fliP* as a sole copy, yielded a similar gold labeling pattern ([Figures 3](#fig3){ref-type="fig"}C, 3D, and [S4](#mmc1){ref-type="supplementary-material"}C). Significantly, in all viewed cases (25), the signal from FliP was restricted to only one end of a connecting nanotube, suggesting that the CORE is exploited for nanotube projection by the producing cell, while docking on a recipient cell is CORE independent. Of note, detection of only a single gold particle (18 nm) associated with the FliP multimeric ring (10 nm in diameter; [@bib16], [@bib26]) is most likely due to resolution limit or steric hindrance. As a control, no gold signal was obtained from cells lacking the HA tagged protein ([Figure S4](#mmc1){ref-type="supplementary-material"}D) or from cells expressing a membrane protein tagged at a site facing the cytoplasm ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F) ([@bib39]). Furthermore, cells harboring a surface-exposed tag in an unrelated membrane protein yielded a scattered pattern, which did not coincide with nanotube emanation sites ([@bib44]) ([Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H). Hence, we conclude that the CORE provides a platform for nanotube emergence.Figure 3FliP Localizes to the Base of NanotubesCells expressing HA-tagged FliP (SH93: *amyE*::P~*hyper-spank*~-*fliP*~2xHA~, *sacA*::P~*hyper-spank*~-*ymdB*, A and B, or SH110: *amyE*::P~*hyper-spank*~-*fliP*~2xHA~, *sacA*::P~*hyper-spank*~-*ymdB, Δmbl*, C and D) were spotted onto EM grids and subjected to immuno-gold XHR-SEM, using primary antibodies against HA and secondary gold-conjugated antibodies. Samples were not coated before observation. Examples of FliP~2xHA~ localization (white dots) at the base of nanotubes are presented (indicated by arrows). Shown are XHR-SEM images that were acquired using TLD-SE (through-lens detector-secondary electron) for nanotubes visualization and vCD (low-kV high-contrast backscattered detector) for gold particle detection, as well as overlay of both images. Schematic below depicts the interpretive cell layout and highlights the nanotube region with gold signal (dashed box) captured by XHR-SEM. Scale bars represent 200 nm. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

Flagellar CORE Complexes Are Used for Nanotube Formation by Diverse Species {#sec2.4}
---------------------------------------------------------------------------

On the basis of our results, we asked whether the flagellar CORE of other bacterial species is bi-functional and similarly to CORE-F~Bs~ can give rise to both flagella and nanotubes. We thus deleted the *CORE* genes from the genomes of *Bm*, a close relative of *Bs*, the Gram-positive human pathogen *Listeria monocytogenes* (*Lm*), and the evolutionary distant *Escherichia coli* (*Ec*) ([Table S1](#mmc1){ref-type="supplementary-material"}). Wild-type, Δ*CORE*, and mutants lacking the flagellum filament (Δ*flagellin*) from all tested species were incubated on a solid surface to induce nanotube formation and subsequently examined using XHR-SEM. While nanotube appendages were plentiful in wild-type and in strains devoid of flagellum filaments, they were absent from the corresponding *CORE* mutants ([Figure 4](#fig4){ref-type="fig"}A), hence corroborating that the flagellar CORE is used by diverse species for nanotube production.Figure 4CORE Is a Widespread Complex with Conserved Functions across Species(A) Wild-type *Bm* (OS2), *Lm* (10403S), and *Ec* (MG1655) and their corresponding mutant strains lacking *CORE* (*ΔCORE*) or gene encoding flagellin (*Δflagellin*) were grown to the mid-logarithmic phase, spotted onto EM grids followed by incubation on LB agar plates for 4 h at 37°C, and visualized using XHR-SEM. Arrows indicate nanotubes. Scale bar represents 500 nm. Right: quantification of the average number of nanotubes displayed per 50 cells by the indicated strains following XHR-SEM analysis. Shown are average values and SD of at least three independent experiments (n ≥ 200 for each strain).(B) Cells of *Bs* (Δ*CORE*) complemented with *Bm* flagellar *CORE* (*CORE-F*~*Bm*~), *Lm* flagellar *CORE* (*CORE-F*~*Lm*~), and *Ec* flagellar *CORE* (*CORE-F*~*Ec*~) were processed as in (A) and visualized using XHR-SEM. Arrows indicate nanotubes. Scale bar represents 500 nm.(C) Quantification of the average number of nanotubes displayed per 50 cells by the indicated strains following XHR-SEM analysis described in (B). Shown are average values and SD of at least three independent experiments (n ≥ 200 for each strain).(D) Assessing molecular exchange in *Bs* Δ*CORE* strain complemented with exogenous *CORE* genes. For protein exchange assay, pairs of a donor (SB463: *amyE*::P~*hyper-spank*~-*cat*-*spec*) (Cm^R^, Spec^R^) and a recipient (SB513: *amyE*::P~*hyper-spank*~-*gfp-kan*) (Kan^R^) parental strains (wild-type) were used. The investigated strains *ΔCORE* and *ΔCORE* complemented with *CORE-F*~*Bm*~, *CORE-F*~*Lm*~, and *CORE-F*~*Ec*~ (controlled by *Bs* P~*fla*/*che*~ promoter) harbor the corresponding genotypes of donor and recipient. Donor and recipient strains were mixed in 1:1 ratio (at two concentrations, 1× and 0.1×) and incubated in LB supplemented with 1 mM IPTG for 4 h at 37°C with gentle shaking. Equal numbers of cells were then spotted onto LB agar (control) and LB agar containing chloramphenicol (Cm) and kanamycin (Kan) (protein exchange) and photographed after 18 h. For plasmid exchange assay, pairs of a donor (GD110: *amyE*::P~*hyper-spank*~-*cat-spec*, pHB201/*cat*, *erm*) (Cm^R^, Spec^R^, Mls^R^) and a recipient (SB513: *amyE*::P~*hyper-spank*~-*gfp-kan*) (Kan^R^) parental strains (wild-type) were used. The investigated strains complemented with exogenous *CORE*s harbor the corresponding genotypes of donor and recipient strains. Cells were mixed in 1:1 ratio (concentration 1×), processed as described for protein exchange, and spotted onto LB agar containing Cm, Kan, and lincomycin (Lin) (plasmid exchange). Cells were incubated at 37°C, and colonies were photographed after 36 h of incubation. For motility assay, wild-type (PY79) and the indicated strains were grown to mid-logarithmic phase, spotted onto LB plates containing 0.3% agar, and photographed after 7 h of incubation at 37°C (motility).(E) A schematic model depicting the modularity of CORE complexes in flagellum and nanotube. CORE-associated components of the nanotube basal body are missing. Flagellum structure was adapted from ([@bib12]).See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc2){ref-type="supplementary-material"}.

We then investigated the cross-species functional conservation of COREs by testing the capacity of foreign flagellar CORE complexes to complement nanotube formation by *CORE* deficient *Bs*. Introducing *CORE-F*~*Bm*~ genes into *Bs* Δ*CORE* mutant prompted the formation of intercellular nanotubular structures to a level close to that of wild-type *Bs* ([Figures 4](#fig4){ref-type="fig"}B and 4C). Compellingly, also *CORE-F*~*Lm*~ and *CORE-F*~*Ec*~ genes induced the formation of nanotubes in *Bs* Δ*CORE*, although of an apparent thin morphology ([Figures 4](#fig4){ref-type="fig"}B and 4C). Interestingly, however, motility was reestablished by *CORE-F*~*Bm*~ but could not be restored by *CORE-F*~*Lm*~ or *CORE-F*~*Ec*~ ([Figure 4](#fig4){ref-type="fig"}D). Consistent with the complete restoration of nanotubes by *CORE-F*~*Bm*~, both protein and plasmid exchange levels were regained to levels comparable with that of wild-type *Bs* ([Figure 4](#fig4){ref-type="fig"}D). In line with the limited nanotube restitution ([Figure 4](#fig4){ref-type="fig"}C), *CORE-F*~*Lm*~ and *CORE-F*~*Ec*~ enabled partial protein exchange but could not support plasmid exchange ([Figure 4](#fig4){ref-type="fig"}D), indicating that additional non-CORE components that differ among species are involved in this process. Taken together, our results suggest that distinct bacterial species carrying flagellar *CORE* genes have the potential to form nanotubes.

CORE Complexes Are Universal and Phylogenetically Widespread {#sec2.5}
------------------------------------------------------------

We next addressed the ubiquity of the *CORE* genes across the bacterial kingdom. Since previous such analyses included primarily genomes of Gram-negative bacteria ([@bib1], [@bib22], [@bib40]), here we attempted to include representatives of the majority of the bacterial phyla. Using the STRING database homology data ([@bib42], [@bib45]), we analyzed 400 species belonging to 18 phyla. We found *CORE* genes to be widespread in all the examined bacterial phyla, typically as part of the flagellum or its homologous injectisome apparatus ([Figure S5](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc2){ref-type="supplementary-material"}). Interestingly, some bacteria lacking a substantial fraction of the gene cohort required for formation of these organelles still harbor the *CORE* genes that could function to nucleate exclusively nanotube biogenesis. These bacteria include *Myxococci* species (phylum Proteobacteria), *Chloracidobacterium thermophilum* (phylum Acidobacteria), and *Succinatimonas hippie* (phylum Proteobacteria) ([Figure S5](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc2){ref-type="supplementary-material"}) ([@bib1], [@bib22]). Overall, this examination emphasizes that a wide spectrum of species possesses the potential to produce nanotubes and use them for molecular exchange.

Discussion {#sec3}
==========

We uncovered that the export apparatus of the flagella, designated CORE, is a dual-functional complex, communally serving as a foundation for both flagella and nanotube generation ([Figure 4](#fig4){ref-type="fig"}E). This complex is likely to promote flagella formation by planktonic bacteria but alternates to support nanotube formation by bacteria grown on solid surfaces. The functional conservation of CORE complexes from distinct bacterial species was revealed by their ability to support nanotube formation in *Bs* mutant lacking endogenous *CORE* genes. Our findings insinuate that CORE-dependent molecular trafficking among bacteria is extensive and broad and includes a large array of cytoplasmic molecules. As such, it fundamentally expands the bacterial metabolic flexibility, facilitating the acquisition of new features. Furthermore, the observation that even plasmid trafficking uses CORE-dependent nanotubes highlights the potential impact of CORE complexes on horizontal gene transfer in nature. In the accompanying study, we discovered a similar set of highly conserved injectisome CORE proteins in EPEC to be implicated in extraction of cytoplasmic molecules from infected human host cells via nanotubes ([@bib34]). On the basis of our findings, we postulate that the CORE represents an evolutionary ancestral functional unit, which subsequently evolved by acquisition of additional components, into nanotube, flagellum, or injectisome.

Some bacteria, including *Vibrio cholerae* and *Helicobacter pylori*, form flagella encased by membranous protrusions, termed "sheathed flagella." Intriguingly, these bacteria were reported to occasionally produce "empty sheaths," with a structure highly resembling nanotubes ([@bib2], [@bib17], [@bib30]). Furthermore, the existence of isolated orphan CORE components in various bacterial genomes, frequently referred to as truncated or incomplete systems ([@bib35], [@bib37]), insinuates their potential nanotube designation.

The discovery that CORE serves as a platform for nanotube biogenesis could provide the foundation for elucidating central aspects of nanotube functionality, such as the selection of the delivered molecular cargo, the source of energy used for cargo transportation, the directionality of nanotube operation, and the fusion mechanism with recipient cell membrane. Further mechanistic insight into nanotube biogenesis and function may escort the development of innovative methodologies, enabling control of intercellular molecular trade among bacteria, to attain intelligent bacterial community design.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Polyclonal anti-HA antibodies (Rabbit)Thermo Fisher ScientificCat\#:71-5500; RRID: [AB_2533988](nif-antibody:AB_2533988){#interref25}Polyclonal anti-GFP antibodies (Rabbit)Laboratory stock ([@bib13])NA18 nm gold-conjugated IgG secondary antibody Goat anti-Rabbit.Jackson ImmunoResearch LaboratoriesCat\#: 111-215-144; RRID: [AB_2338017](nif-antibody:AB_2338017){#interref30}**Chemicals, Peptides, and Recombinant Proteins**ChloramphenicolSigma-AldrichCat\#: C0378TetracyclineSigma-AldrichCat\#: 87128KanamycinUS BiologicalCat\#: K0010LincomycinSigma-AldrichCat\#: 62143-5GErythromycinSigma-AldrichCat\#: E0774SpectinomycinSigma-AldrichCat\#: S4014-5GAmpicillinSigma-AldrichCat\#: A9518-25GIPTG (Isopropyl β-D-1-thiogalactopyranoside)Sigma-AldrichCat\#: I6758-5GD-XyloseSigma-AldrichCat\#: X1500-1KGSucroseJ.T.BakerCat\#: 4072-05Polyethylene glycol 8000PromegaCat\#: V3011D-SorbitolSigma-AldrichCat\#: S6021ParaformaldehydeElectron Microscopy SciencesCat\#: 15710GlutaraldehydeElectron Microscopy SciencesCat\#: 16020Sodium Cacodylate Buffer (pH 7.4)Electron Microscopy SciencesCat\#: 11650FM4-64Molecular probes/ Thermo Fisher ScientificCat\#: T13320**Critical Commercial Assays**Q5 High-Fidelity DNA PolymeraseNEW ENGLAND BioLabsCat\#: M0491SGibson Assembly Master MixNEW ENGLAND BioLabsCat\#: E2611LQuick Ligation KitNEW ENGLAND BioLabsCat\#: M2200SRQ1 RNase-free DNasePromegaCat\#: M6101qScript cDNA synthesis kitQuanta BiosciencesCat\#: 95047-25PerfeCTa SYBR Green FastMix[Quanta](astm:Quanta){#intref0010} BiosciencesCat\#: 95073-250**Experimental Models: Organisms/Strains**PY79 (*B. subtilis* wild type)[@bib47]NAAR16 (*amyE::*P~*rrnE*~*-gfp-spec*)[@bib38]NAGD215 (Δ*hag*::*erm*)[@bib13]NAGD110 (*amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)[@bib13]NAGD267 (Δ*hag*::*erm*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)Laboratory stockNAGD268 (Δ*hag*::*erm*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)Laboratory stockNASB463 (*amyE*::P~*hyper*-*spank*~-*cat*-*spec*)[@bib13]NASB513 (*amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)[@bib13]NAGB61 (Δ*ymdB*::*tet*)[@bib14]NAGB168 (Δ*ymdB*::*tet*, *amyE*::P~*hyper*-*spank*~-*ymdB-spec*, Δ*hag*::*erm*)[@bib14]NAIB11 (*Δmbl::erm*)[@bib5]NAET13 (*amyE*::P~*hyper*-*spank*~-*yueB*-*yfp*-*spec*)[@bib44]NABDR524 (*amyE*::P~*xylA*~-*spoIVFB*-*gfp*-*cat*)[@bib39]NASH8 (Δ*flgB-fliF::tet*, P~*fla/che*~-*fliG-cheD*)This studyNASH9 \[Δ*CORE (fliO-flhA)::tet,* P~*fla/che*~-*flhF-cheD*\]This studyNASH30 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE::*P~*rrnE*~*-gfp-spec*)This studyNASH31 (*sacA::*P~*fla/che*~-*fliO-flhA*-*spec*)This studyNASH33 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec*)This studyNASH47 (*flhA-gfp-kan)*This studyNASH55 (*flhA-gfp-kan*, Δ*ymdB*::*tet*, *amyE*::P~*hyper*-*spank*~-*ymdB-spec*, Δ*hag*::*erm)*This studyNASH79 (*sacA*::P~*hyper*-*spank*~-*ymdB-kan*)This studyNASH86 (*amyE*::P~*hyper-spank*~-*fliP*~2xHA~-*spec*)This studyNASH93 (*amyE*::P~*hyper-spank*~-*fliP*~2xHA~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan*)This studyNASH103 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*)This studyNASH104 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*)This studyNASH105 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*)This studyNASH106 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*)This studyNASH107 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*)This studyNASH108 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*)This studyNASH110 (*amyE*::P~*hyper-spank*~-*fliP*~2xHA~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan, Δmbl::erm*)This studyNASH115 \[*sacA::*P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\]This studyNASH116 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\]This studyNASH150 (*amyE*::P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*)This studyNASH151 (*amyE*::P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan*)This studyNASH161 (*amyE*::P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan*, *Δmbl::erm*)This studyNASH169 \[*amyE::*P~*hyper-spank*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\]This studyNASH170 \[Δ*fliO-flhA::tet*, *amyE::*P~*hyper-spank*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\]This studyNASH177 (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*)This studyNASH203 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*)This studyNASH204 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*)This studyNASH205 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*)This studyNASH206 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*)This studyNASH207 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*)This studyNASH208 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*)This studyNASH209 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*\]This studyNASH210 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*\]This studyNASH244 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*)This studyNASH245 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*~2xHA~-*spec*)This studyNASH247 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*~2xHA~-*spec, Δmbl::erm*)This studyNASH255 (*amyE*::P~*hyper*-*spank*~-*yueB*-*yfp*-*spec, sacA*::P~*hyper*-*spank*~-*ymdB-kan*)This studyNASH256 (*amyE*::P~*xylA*~-*spoIVFB*-*gfp*-*cat, sacA*::P~*hyper*-*spank*~-*ymdB-kan*)This studyNASH257 (*amyE*::P~*hyper*-*spank*~-*yueB*-*yfp*-*spec, sacA*::P~*hyper*-*spank*~-*ymdB-kan, Δmbl::erm*)This studyNASH258 (*amyE*::P~*xylA*~-*spoIVFB*-*gfp*-*cat, sacA*::P~*hyper*-*spank*~-*ymdB-kan, Δmbl::erm*)This studyNASH12 (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH13 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH41 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec, amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH119 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH120 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH121 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH122 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH123 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH124 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH131 \[Δ*fliO-flhA::tet*, *sacA::* P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*\]This studyNASH182 (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH213 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH214 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH215 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH216 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH217 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH218 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH219 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*\]This studyNASH220 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*\]This studyNASH248 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)This studyNASH16 (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*, *amyE*::P~*hyper*-*spank*~ -*cat*-*spec*)This studyNASH17 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~ -*cat*-*spec*)This studyNASH58 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH125 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH126 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH127 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH128 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH129 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH130 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH132 \[Δ*fliO-flhA::tet*, *sacA::* P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*\]This studyNASH183 (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH223 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH224 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH225 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH226 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH227 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH228 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH229 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*\]This studyNASH230 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*\]This studyNASH249 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*)This studyNASH22 (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH23(Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH62 (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH134 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH135 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH136 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH137 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH138 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH139 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH181 (Δ*hag*::*erm*, pHB201/*cat*, *erm*)This studyNASH185 (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH233 (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH234 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spe*, pHB201/*cat*, *erm*)This studyNASH235 (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spe*, pHB201/*cat*, *erm*)This studyNASH236 (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spe*, pHB201/*cat*, *erm*)This studyNASH237 (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH238 (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNASH239 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*\]This studyNASH240 \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*\]This studyNASH250 (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*)This studyNAOS2 (*Bacillus megaterium* wild type isolate)[@bib41]NA*Bm* Δ*CORE* (*fliO-flhA*)This studyNA*Bm* Δ*flagellin* (*hag*)This studyNA*Escherichia coli* K-12 MG1655Laboratory stockNAXTL634 (Template for *tet*::*sacB* cassette)[@bib28]NARP7802 \[*Escherichia coli* K-12 MG1655 Δ *fliOPQR*\]This studyNARP7809 \[*Escherichia coli* K-12 MG1655 Δ*CORE* (*fliOPQRflhBA*)\]This studyNA*Ec* DY378 (1974) \[W3110 λcI857, Δ(cro-*bioA*)\][@bib48]SK2462 (*Ec* DY378 Δ*fliC*::*kan*)This studyNASK2468 \[*Ec* K-12 MG1655 Δ*flagellin* (*fliC*::*kan*)\]This studyNA*Listeria monocytogenes* 10403SKindly provided by Ran Nir-Paz (Hebrew U)NA*Lm* 10403S Δ*CORE* (*fliP-flhA*)This studyNA*Lm* 10403S Δ *flagellin* (*flaA*)This studyNA**Oligonucleotides**Primers used in this study are listed in [Table S3](#mmc1){ref-type="supplementary-material"}.All primers were designed during this study, and synthesized by Integrated DNA Technologies (IDT).NA**Recombinant DNA**pDR111 (*amyE::*P~*hyper-spank*~-*spec*)Kindly provided by David Rudner (Harvard U)NApHB201 (*cat*, *erm*)[@bib7]NApKL168 (*gfp-kan*)[@bib27]NApKD46 (λ RED genes, Amp^r^)[@bib9]NApRP7358 \[P~*tac*~-*CORE-F*~*Ec*~ (*fliOPQRflhBA*)\][@bib34]NApSH13 (*flhA-gfp-kan*)This studyNApSH17 (*amyE::*P~*hyper-spank*~-*fliP*~2xHA~-*spec*)This studyNApSH19 (*amyE::*P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*)This studyNApSH21 \[*amyE::*P~*hyper-spank*~- *CORE-F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\]This studyNApLR16- PhesKindly provided by Anat Herskovits (Tel Aviv U) ([@bib3])NApLR16-AB1This studyNApSH22 (pLR16-*Lm flaA* int)This studyNApSH23 (pDG1514-*Bm hag* int)This studyNA**Other**Carbon film on 300 square mesh copper gridsElectron Microscopy SciencesCat\#: CF300-CuLysing Matrix B BulkMP BiomedicalsCat\#: 6540-428

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Sigal Ben-Yehuda (<sigalb@ekmd.huji.ac.il>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Details on bacterial strain construction {#sec4.3.1}

*Bs* strains are derivatives of the wild-type strain PY79, *Bm* is a wild-type soil isolate (OS2), *Ec* strains are derivatives of the wild-type strain K-12 MG1655, *Lm* strains are derivatives of the wild-type strain 10403S. Bacterial strains and plasmids are listed in Key resources table, and primers are listed in [Table S3](#mmc1){ref-type="supplementary-material"}.

For gene replacement strategy in *Bs*, indicated primer pairs (P1-P4; [Table S3](#mmc1){ref-type="supplementary-material"}) were used to amplify the flanking genomic regions of the corresponding gene. The *fla/che* promoter region was amplified using the primers P~*flgB*~1-2. PCR products were used for Gibson assembly (NEB, USA), together with the respective antibiotic resistance gene ([@bib19]) The resultant product was used to transform PY79 to obtain the mutant allele.

**SH8** (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *flgB-fliF* KO P1-P4 and P~*flgB*~1-2. **SH9** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *CORE* KO P1-P4 and P~*flgB*~1-2. **SH12** (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH8 with genomic DNA (gDNA) from strain SB513. **SH13** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH9 with gDNA from strain SB513. **SH16** (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*, *amyE*:: P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH8 with gDNA from strain SB463. **SH17** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*:: P~*hyper*-*spank*~ -*cat*-*spec*) was constructed by transforming SH9 with gDNA from strain SB463. **SH22** (Δ*flgB-fliF::tet,* P~*fla/che*~-*fliG-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH8 with pHB201. **SH23** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH9 with pHB201. **SH30** (Δ*fliO-flhA::tet,*P~*fla/che*~-*flhF-cheD*, *amyE::*P~*rrnE*~*-gfp-spec*) was constructed by transforming gDNA SH9 with from strain AR16. **SH31** (*sacA::*P~*fla/che*~-*fliO-flhA*-*spec*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *Bs CORE* comp1-2 and Comp P~*flgB*~1-2. **SH33** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec*) was constructed by transforming SH9 with gDNA from strain SH31. **SH41** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec, amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH33 with gDNA from strain SB513. **SH47** (*flhA-gfp-kan)* was constructed by transforming PY79 with pSH13. **SH55** (*flhA-gfp-kan*, Δ*ymdB*::*tet*, *amyE*::P~*hyper*-*spank*~-*ymdB-spec*, Δ*hag*::*erm)* was constructed by transforming GB168 with gDNA from strain SH47. **SH58** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH33 with gDNA from strain SB463. **SH62** (Δ*fliO-flhA::tet,* P~*fla/che*~-*flhF-cheD*, *sacA::*P~*fla/che*~-*fliO-flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH58 with pHB201. **SH79** (*sacA*::P~*hyper*-*spank*~-*ymdB-kan*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4 and Comp P~*HS*~1-*ymdB* R. P~*hyper*-*spank*~-*ymdB* was amplified from GB168 gDNA using Comp P~*HS*~1-*ymdB* R primers. **SH86** (*amyE*::P~*hyper-spank*~-*fliP*~2xHA~-*spec*) was constructed by transforming PY79 with pSH17. **SH93** (*amyE*::P~*hyper-spank*~-*fliP*~2xHA~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan*) was constructed by transforming SH79 with gDNA from strain SH86. **SH96** (*flhA-gfp-kan*, *amyE::*P~*hag*~*-hag*^T209C^-*spec*) was constructed by transforming DS1895 with gDNA from strain SH47. **SH103** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *fliO* KO P1-P4 and P~*flgB*~1-2. **SH104** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *fliP* KO P1-P4 and P~*flgB*~1-2. **SH105** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *fliQ* KO P1-P4 and P~*flgB*~1-2. **SH106** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *fliR* KO P1-P4 and P~*flgB*~1-2. **SH107** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *flhB* KO P1-P4 and P~*flgB*~1-2. **SH108** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *flhA* KO P1-P4 and P~*flgB*~1-2. **SH110** (*amyE*::P~*hyper-spank*~-*fliP*~2xHA~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan, Δmbl::erm*) was constructed by transforming SH93 with gDNA from strain IB11. **SH115** \[*sacA::*P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\] was constructed using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *Ec CORE* comp 1-2 and Comp P~*flgB*~1-2a. *CORE*-*F*~*Ec*~ (*fliOPQRflhBA*) was amplified from pRP7358 using primers *Ec CORE* comp 1-2. **SH116** \[Δ*fliO-flhA::tet*, *sacA:* P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\] was constructed by transforming SH9 with gDNA from strain SH115. **SH119** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH103 with gDNA from strain SB513. **SH120** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH104 with gDNA from strain SB513. **SH121** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH105 with gDNA from strain SB513. **SH122** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*)was constructed by transforming SH106 with gDNA from strain SB513. **SH123** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH107 with gDNA from strain SB513. **SH124** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH108 with gDNA from strain SB513. **SH125** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH103 with gDNA from strain SB463. **SH126** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH104 with gDNA from strain SB463. **SH127** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH105 with gDNA from strain SB463. **SH128** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH106 with gDNA from strain SB463. **SH129** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH107 with gDNA from strain SB463. **SH130** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH108 with gDNA from strain SB463. **SH131** \[Δ*fliO-flhA::tet*, *sacA::* P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*\] was constructed by transforming SH116 with gDNA from strain SB513. **SH132** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*\] was constructed by transforming SH116 with gDNA from strain SB463. **SH134** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH125 with pHB201. **SH135** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH126 with pHB201. **SH136** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH127 with pHB201. **SH137** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH128 with pHB201. **SH138** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH129 with pHB201. **SH139** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH130 with pHB201. **SH150** (*amyE*::P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*) was constructed by transforming PY79 with pSH19. **SH151** (*amyE*::P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan*) was constructed by transforming SH79 with gDNA from strain SH150. **SH161** (*amyE*::P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*, *sacA*::P~*hyper-spank*~-*ymdB-kan*, *Δmbl::erm*) was constructed by transforming SH150 with gDNA from strain IB11. **SH169** \[*amyE::*P~*hyper-spank*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\] was constructed by transforming PY79 with pSH21. **SH170** \[Δ*fliO-flhA::tet*, *amyE::*P~*hyper-spank*~-*CORE*-*F*~*Ec*~ (*fliOPQRflhBA*)-*spec*\] was constructed by transforming SH9 with gDNA from strain SH169. **SH177** (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*) was constructed using Gibson assembly kit (NEB, USA) utilizing primers *fli*I KO P1-P4 and P~*flgB*~1-2. **SH181** (Δ*hag*::*erm*, pHB201/*cat*, *erm*) was constructed by transforming GD215 with pHB201. **SH182** (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH177 with gDNA from strain SB513. **SH183** (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH177 with gDNA from strain SB463. **SH185** (Δ*fliI::tet,* P~*fla/che*~-*fliJ-cheD*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH183 with pHB201. **SH203** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*) was constructed by transforming SH103 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *fliO* comp1-2 and Comp P~*flgB*~1-R. **SH204** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*) was constructed by transforming SH104 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *fliP* comp1-2 and Comp P~*flgB*~1-R. **SH205** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*) was constructed by transforming SH105 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *fliQ* comp1-2 and Comp P~*flgB*~1-R. **SH206** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*) was constructed by transforming SH106 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *fliR* comp1-2 and Comp P~*flgB*~1-R. **SH207** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*) was constructed by transforming SH107 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *flhB* comp1-2 and Comp P~*flgB*~1-R. **SH208** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*) was constructed by transforming SH108 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *flhA* comp1-2 and Comp P~*flgB*~1-R. **SH209** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*\] was constructed by transforming SH9 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *Lm CORE* comp1-2 and Comp P~*flgB*~1-R. *CORE*-*F*~*Lm*~ (*fliPQRflhBA*) was amplified from *Lm* (10403S) gDNA using primers *Lm CORE* comp 1-2. **SH210** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*\] was constructed by transforming SH9 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *Bm CORE* comp1-2 and Comp P~*flgB*~1-R. *CORE*-*F*~*Bm*~ (*fliOPQRflhBA*) was amplified from *Bm* (OS2) gDNA using primers *Bm CORE* comp 1-2. **SH213** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH203 with gDNA from strain SB513. **SH214** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH204 with gDNA from strain SB513. **SH215** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH205 with gDNA from strain SB513. **SH216** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH206 with gDNA from strain SB513. **SH217** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH207 with gDNA from strain SB513. **SH218** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH208 with gDNA from strain SB513. **SH219** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*\] was constructed by transforming SH209 with gDNA from strain SB513. **SH220** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*\] was constructed by transforming SH210 with gDNA from strain SB513. **SH223** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH203 with gDNA from strain SB463. **SH224** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH204 with gDNA from strain SB463. **SH225** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH205 with gDNA from strain SB463. **SH226** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH206 with gDNA from strain SB463. **SH227** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH207 with gDNA from strain SB463. **SH228** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH208 with gDNA from strain SB463. **SH229** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~(*fliPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*\] was constructed by transforming SH209 with gDNA from strain SB463. **SH230** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*\] was constructed by transforming SH210 with gDNA from strain SB463. **SH233** (Δ*fliO::tet,* P~*fla/che*~-*fliP-cheD, sacA::*P~*fla/che*~-*fliO*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH223 with pHB201. **SH234** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spe*, pHB201/*cat*, *erm*) was constructed by transforming SH224 with pHB201. **SH235** (Δ*fliQ::tet,* P~*fla/che*~-*fliR-cheD, sacA::*P~*fla/che*~-*fliQ*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spe*, pHB201/*cat*, *erm*) was constructed by transforming SH225 with pHB201. **SH236** (Δ*fliR::tet,* P~*fla/che*~-*flhB-cheD, sacA::*P~*fla/che*~-*fliR*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spe*, pHB201/*cat*, *erm*) was constructed by transforming SH226 with pHB201. **SH237** (Δ*flhB::tet,* P~*fla/che*~-*flhA-cheD, sacA::*P~*fla/che*~-*flhB*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH227 with pHB201. **SH238** (Δ*flhA::tet,* P~*fla/che*~-*flhF-cheD, sacA::*P~*fla/che*~-*flhA*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH228 with pHB201. **SH239** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Lm*~ (*fliPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*\] was constructed by transforming SH229 with pHB201. **SH240** \[Δ*fliO-flhA::tet*, *sacA::*P~*fla/che*~-*CORE*-*F*~*Bm*~ (*fliOPQRflhBA*)-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*\] was constructed by transforming SH230 with pHB201. **SH244** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*) was constructed by transforming SH104 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, *fliO* comp 1-*fliP* comp 2 and Comp P~*flgB*~1-R. **SH245** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*~2xHA~-*spec*) was constructed by transforming SH104 with complementation construct generated using Gibson assembly kit (NEB, USA) utilizing primers *sacA* P1-P4, Comp P~*flgB*~1-R, and *fliOP*~*2xHA*~ construct. *fliOP* was amplified using *fliO* comp 1 and *fliP* ORF R (2X HA), followed by a second round of PCR using primers *fliP* comp 1 and 2X HA R to finally obtain *fliOP*~*2xHA*~ construct. **SH247** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*~2xHA~-*spec, Δmbl::erm*) was constructed by transforming SH245 with gDNA from strain IB11. **SH248** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*gfp*-*kan*) was constructed by transforming SH244 with gDNA from strain SB513. **SH249** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*) was constructed by transforming SH244 with gDNA from strain SB463. **SH250** (Δ*fliP::tet,* P~*fla/che*~-*fliQ-cheD, sacA::*P~*fla/che*~-*fliO-fliP*-*spec*, *amyE*::P~*hyper*-*spank*~-*cat*-*spec*, pHB201/*cat*, *erm*) was constructed by transforming SH249 with pHB201. **SH255** (*amyE*::P~*hyper*-*spank*~-*yueB*-*yfp*-*spec, sacA*::P~*hyper*-*spank*~-*ymdB-kan*) was constructed by transforming ET13 with gDNA from strain SH79. **SH256** (*amyE*::P~*xylA*~-*spoIVFB*-*gfp*-*cat, sacA*::P~*hyper*-*spank*~-*ymdB-kan*) was constructed by transforming BDR524 with gDNA from strain SH79. **SH257** (*amyE*::P~*hyper*-*spank*~-*yueB*-*yfp*-*spec, sacA*::P~*hyper*-*spank*~-*ymdB-kan, Δmbl::erm*) was constructed by transforming ET13 with gDNA from strain IB11. **SH258** (*amyE*::P~*xylA*~-*spoIVFB*-*gfp*-*cat, sacA*::P~*hyper*-*spank*~-*ymdB-kan, Δmbl::erm*) was constructed by transforming BDR524 with gDNA from strain IB11.

Method Details {#sec4.4}
--------------

### General growth conditions {#sec4.4.1}

All general methods for *Bs* were carried out as described previously ([@bib20]). *Bs* cultures were inoculated at OD~600~ 0.05 from an overnight culture and growth was carried out at 37°C in LB medium (Difco). For strains harboring genes under inducible promoters, 1 mM IPTG (Sigma-Aldrich) or 0.5% xylose (Sigma-Aldrich) was added to the medium. Antibiotics were used at the following concentrations: kanamycin (5 μg/ml, US Biological), chloramphenicol (6 μg/ml, Sigma-Aldrich), lincomycin (25 μg/ml, Sigma-Aldrich), erythromycin (1 μg/ml, Sigma-Aldrich), tetracycline (10 μg/ml, Sigma-Aldrich), spectinomycin (100 μg/ml, Sigma-Aldrich).

Transformation into *Bm* (OS2) cells was carried out as previously described ([@bib33]). *Bm* cells were grown up to 1.0 OD~600~ (10 ml). Cells were then washed with electroporation buffer \[25% PEG 8000 (Promega) and 0.1 M sorbitol (Sigma-Aldrich)\] and resuspended in 1 mL of the same buffer. Electroporation was carried out with 0.1 mL of cells supplemented with 500 ng of linear DNA or plasmid DNA at 1500 V (Bio-Rad). Cells were then resuspended in 1 mL LB, incubated at 37°C for 1 hr, and plated on LB plates containing 5 μg/ml tetracycline.

Scarless deletions of *E. coli* were constructed using λ Red system and *tet-sacB* cassette as described ([@bib9], [@bib28]). 50 bp of upstream and downstream sequences of *fliOPQR* ORFs were included in the forward primer 3907 and reverse primer 3908, respectively. These primers were used for PCR amplifying *tet-sacB* cassette from XTL634. Next, the cassette was inserted into MG1655 strain, containing pKD46 carrying λ Red genes (γ, β and *exo*) and a temperature sensitive origin. Around 1 Kb of recombination sequences upstream and downstream of *fliOPQR* were PCR amplified using primers 3909, 3912, 3950 and 3951. The upstream and downstream recombination sequences were ligated together by isothermal assembly ([@bib18]). The *tet-sacB* cassette was then replaced with the ligated DNA using similar λ Red system and selected on 6% sucrose (J.T.Baker). Next, the plasmid pKD46 was cured at 42°C to construct the strain **RP7802** (Δ*fliOPQR*). Next, *tet-sacB* cassette was PCR amplified using primers 3914 and 3915. The cassette was inserted in RP7802 strain containing pKD46 using λ Red system. Around 1 Kb of recombination sequences upstream and downstream of *flhBA* were PCR amplified using primers 3952, 3953, 3954 and 3955. The upstream and downstream recombination sequences were ligated together by isothermal assembly and the *tet-sacB* cassette was then replaced with the ligated DNA using similar λ Red system. Next, the plasmid pKD46 was cured, and strain **RP7809** (Δ*CORE* \[*fliOPQRflhBA*\]) constructed. Δ*fliC*::*kan* allele was PCR amplified with primers 311 and 312 using pKD4 as a template. Wild-type *fliC* of DY378 was disrupted by λ-red recombination of Δ*fliC*::*kan* allele and SK2462 strain was constructed ([@bib9]). Then Δ*fliC*::*kan* allele was transferred to wild-type MG1655 by P1 transduction with SK2462 lysate to construct SK2468 ([@bib43]).

Deletion mutant in *Lm* was constructed using pLR16-Phes as previously described ([@bib3]). In brief, pLR16-AB1 was transformed into *E. coli* SM-10 strain and subsequently transferred to *Lm* 10403S by conjugation. *Lm* transconjugants were selected by plating on LB agar plates supplemented with 2% glucose and containing 7.5 μg/ml chloramphenicol and 100 μg/ml Streptomycin. Transconjugants were then passaged in LB supplemented with 2% glucose and plated to obtain single colonies. Colonies were tested for sensitivity to chloramphenicol. Chloramphenicol sensitive colonies were further verified to contain the desired mutation by PCR. For disruption of the *flaA* gene, pSH22 was transformed into *E. coli* SM-10 strain and transferred to *Lm* 10403S by conjugation. *Lm* transconjugants were selected by plating on LB agar plates supplemented with 2% glucose and containing 7.5 μg/ml chloramphenicol and 100 μg/ml Streptomycin. Transconjugants were then passaged in LB supplemented with 2% glucose and 10 μg/ml chloramphenicol at 41°C and plated to obtain *flaA* disruption mutants.

### Details on plasmid construction {#sec4.4.2}

Plasmid constructions were performed in *E. coli* DH5α using standard methods.

**pSH13** (*flhA-GFP-kan*) was constructed by amplifying the 3′ region of *flhA* using the gDNA of wild-type *Bs* strain PY79, using primers *flhA* CT-F-EcoRI and *flhA* CT-R-*Xho*I. The PCR-amplified DNA was digested with EcoRI and *Xho*I and was cloned into pKL168 digested with the same enzymes.

**pSH17** (*amyE::*P~*hyper-spank*~-*fliP*~2xHA~-*spec*) was constructed by amplifying *fliP* using the gDNA of wild-type *Bs* strain PY79, using primers *fliP* ORF F (*Hind*III) and *fliP* ORF R (2xHA), followed by a second round of PCR using primers *fliP* ORF F (*Hind*III) and 2xHA R (*Sph*I). The PCR-amplified DNA was digested with *Hind*III and *Sph*I and was cloned into pDR111 digested with the same enzymes.

**pSH19** (*amyE::*P~*hyper-spank*~-*fliP*~2xHA-LOOP~-*spec*) was constructed by amplifying the 5′ and 3′ regions of *fliP* using the gDNA of wild-type *Bs* strain PY79. 5′ region of *fliP* was amplified using primers *fliP* ORF F (pDR111) and *fliP* NT R (GSS/2xHA), and the 3′ region of *fliP* was amplified using primers *fliP* CT F (GSS/2xHA) and *fliP* CT R (pDR111). The PCR-amplified DNA was cloned into pDR111 digested with *Hind*III and *Sph*I using Gibson assembly kit (NEB, USA).

**pSH21** \[*amyE::*P~*hyper-spank*~-*CORE-F*~*Ec*~ (*fliOPQR flhBA*)-*spec*\] was constructed by amplifying the *Ec CORE* using the plasmid pRP7358, using primers *Ec fliO-flhA* F (pDR111) and *Ec fliO-flhA* R (pDR111). The PCR-amplified DNA was cloned into pDR111 digested with *Hind*III and *Sph*I using Gibson assembly kit (NEB, USA).

**pLR16-AB1** was constructed by amplifying approximately 1000bp fragments upstream of *fliP* and downstream of *flhA* using primers *Lm CORE* P1-P2 and *Lm CORE* P3-P4 respectively. The fragments were joined using Gibson assembly kit (NEB, USA) and further amplified by PCR using primers *Lm CORE* P1 and P4. The resultant PCR product was digested with *Xho*I and SalI and cloned into pLR16-Phes digested with the same enzymes.

**pSH22** (pLR16-*Lm flaA* int) was constructed by amplifying approximately 450bp fragment of the *Lm flaA* gene, using primers *Lm flaA* int F and *Lm flaA* int R. The PCR-amplified DNA was cloned into pLR16-Phes digested with SalI using Gibson assembly kit (NEB, USA).

**pSH23** (pDG1514-*Bm hag* int) was constructed by amplifying approximately 450bp fragment of the *Bm hag* gene, using primers *Bm hag* int F (SalI) and *Bm hag* int R (BamHI). The PCR-amplified DNA was digested with SalI and BamHI and was cloned into pDG1514 digested with the same enzymes.

### Nanotube visualization by XHR-SEM {#sec4.4.3}

Nanotube visualization was carried out as previously described ([@bib14]). Accordingly, *Bs*, *Bm*, *Ec* and *Lm* cells grown to mid logarithmic phase were spotted onto EM grids (mesh copper grids, EMS) placed over LB agar plates and incubated for 4 hr at 37°C. Cells were then washed 3 times with PBS × 1, fixed with 2% paraformaldehyde (Electron Microscopy Sciences) and 0.01% glutaraldehyde (Electron Microscopy Sciences) in sodium cacodylate buffer (0.1 M, pH 7.2, Electron Microscopy Sciences) for 10 min at 25°C. Cells were left overnight for fixation in 2% glutaraldehyde in sodium cacodylate buffer (0.1 M, pH 7.2) at 4°C. For cell dehydration, EM grids underwent a series of washes in increasing concentrations of ethanol (25, 50, 75, and 96%) (J.T.Baker) and kept in vacuum till visualization. Samples were coated and observed using Through-Lens Detector operated at Secondary Electron (TLD-SE) mode by Magellan XHR SEM (FEI).

### Immuno-XHR-SEM analysis {#sec4.4.4}

Immuno-XHR-SEM analysis was carried out as previously described ([@bib14], [@bib41]). *Bs* cells were grown on EM grids (mesh copper grids, EMS), and grid-attached cells were washed three times with PBS × 1, fixed with 2% paraformaldehyde and 0.01% glutaraldehyde in sodium cacodylate buffer (0.1 M, pH 7.2) for 10 min at 25°C. Subsequently, grids were washed 3 times in PBS × 1, incubated in PBS × 1 containing 2% BSA (Amresco) and 0.1% Tween 20 (J.T.Baker) for 30 min at 25°C, and washed twice with PBS × 1. Next, grids were incubated for 2 hr at 25°C with rabbit anti-HA antibodies (Thermo Fisher Scientific, USA) or rabbit anti-GFP, diluted 1:1000 in PBS × 1 containing 1% BSA. Grids were then washed 3 times with PBS × 1 and incubated for 1 hr at 25°C with 18nm gold-conjugated goat anti-rabbit antibodies (Jackson ImmunoResearch Laboratories, USA), diluted 1:500 in PBS × 1. Grids were washed 3 times with PBS × 1 and fixed with 2.5% glutaraldehyde in sodium cacodylate buffer (0.1 M, pH 7.2) for 1 hr at 25°C. Grids were then washed gently with water, and cells were dehydrated by exposure to a graded series of ethanol washes (25, 50, 75, 95, and 100% ( × 2); 10 min each), samples were kept in vacuum till visualization. Specimens were imaged without coating by Magellan XHR SEM (FEI) using Through-Lens Detector operated at Secondary Electron (TLD-SE) and Low-voltage high-Contrast backscatter electron Detector (vCD).

### Molecular exchange assay {#sec4.4.5}

For detecting molecular exchange, antibiotic transfer assay was carried out as described previously ([@bib13]) with some modifications. Donor and recipient strains used for the molecular exchange assays are listed in the Key resources table. Respective donor and recipient strains were grown to mid logarithmic phase, after which cells were mixed in 1:1 ratio (OD~600~ = 0.8 or 0.08) and incubated in LB supplemented with 1 mM IPTG for 4 hr at 37°C with gentle shaking. Equal numbers of cells were spotted onto either double selective LB plates containing chloramphenicol (6 μg/ml) and kanamycin (5 μg/ml) for detection of protein exchange, or triple selective LB plates containing chloramphenicol, kanamycin and lincomycin (25 μg/ml) for detection of plasmid exchange. As a control, cells were spotted onto LB plates lacking antibiotics. Plates were incubated at 37°C.

### Motility assay {#sec4.4.6}

Motility assay was carried out as previously described ([@bib25]) with some modifications. Cells were grown to mid logarithmic phase in LB and concentrated 10 times to OD~600~ 5.0. 5 μL of the cell suspension was spotted on freshly prepared LB plates containing 0.3% agar, incubated at 37°C for 7-9 hr, and imaged over time.

### Fluorescence microscopy {#sec4.4.7}

For visualization of FlhA-GFP, SpoIVFB-GFP and YueB-YFP, exponentially growing cells were harvested at an OD~600~ 0.5, washed with PBS × 1 and observed by fluorescence microscopy. For staining bacterial membrane and nanotubes, exponentially growing cells were harvested and resuspended in PBS × 1 containing 1 μg/ml FM4-64 (Molecular Probes, Thermo Fisher Scientific) and visualized by fluorescence microscopy. *Bs*-*Bm* competition assays were carried out as described previously ([@bib41]). Overnight cultures of *Bs* and *Bm* were diluted to OD~600~ 0.1, mixed, and mounted onto a metal ring (A-7816, Invitrogen) filled with LB agarose (1.5%). Cells were incubated in a temperature-controlled chamber at 37°C, and followed by fluorescence microscopy. Cells were visualized by Eclipse Ti microscope (Nikon, Japan), equipped with CoolSnap HQII camera (Photometrics, Roper Scientific, USA). System control and image processing were performed with NIS Elements AR 4.3 (Nikon, Japan).

### RNA isolation and qRT-PCR {#sec4.4.8}

RNA was extracted from *Bs* cells grown to the mid logarithmic phase by FastRNA Pro Blue kit (MP Biomedicals) according to the manufacturer protocol. RNA concentration was determined using NanoDrop 2000C (Thermo Scientific). 2 μg RNA from each sample was treated with RQ1 DNase (2 Units, Promega), and subjected to cDNA synthesis using qScript cDNA synthesis kit (Quanta Biosciences), according to the manufacturer protocol. qRT-PCR reactions were conducted using PerfeCTa SYBR Green FastMix (Quanta Biosciences), and fluorescence detection was performed using Applied Biosystems StepOnePlus system according to manufacturer instructions. RNA from 16S rRNA was used to normalize expression. Relative gene expression and melt curve analysis was done using the Applied Biosystems StepOnePlus software (v. 2.3). Each assay was performed in duplicates with at least two RNA templates prepared from independent biological repeats. qRT-PCR primers were designed using Primer3 software (v. 0.4.0, available online).

### Phylogenetic analysis {#sec4.4.9}

In order to study the evolutionary conservation of the CORE complex we focused on seven proteins of *Bs* 168: the five CORE complex proteins and two exclusive proteins of the flagellar apparatus. In addition, we analyzed three proteins from *E. coli* O157:H7 *str.* EDL933 and one protein from *C. trachomatis* D/UW-3/CX, which are unique to the T3SS. These were searched in each of the core genomes in the STRING database, using STRING's protein homology data ([@bib42]) and analyzed by custom python scripts to determine the conservation of the query proteins ([Table S2](#mmc2){ref-type="supplementary-material"}). Sequence similarity scores \< 0.1 were discarded. The conservation vectors of the species in each phylum were clustered using hierarchical clustering ([Figure S5](#mmc1){ref-type="supplementary-material"}). Additionally, all species from all phyla were clustered together, and species clustering along with *M. fulvus* were inspected further to assess whether they include only the CORE proteins without other T3SS or flagella proteins, in a similar manner to *M. fulvus*.

PSI-BLAST was used to search several flagella unique proteins from *Bs*, along with several T3SS unique proteins from both Enterohemorrhagic *E. coli* and *C. trachomatis*, against the proteomes of the suspected species from the NCBI Assembly database. Hits adhering to stringent threshold of E-value \< 0.01, spanning longer than half the length of the query with identity \> 0.2, were considered putative homologs. Furthermore, a literature search was carried out by searching PubMed for the relevant species names alongside "Type III secretion system" and "flagella." Species that had putative hits for \< 20% of the proteins in all categories and had no relevant results in the literature search were considered to harbor only the CORE proteins.

Quantification and statistical analysis {#sec4.5}
---------------------------------------

Unless stated otherwise, bar charts display a mean ± SD from at least 3 independent biological experiments. Quantification of nanotubes were done manually. MS Excel was used for all statistical analysis, data processing and presentation.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S5 and Tables S1 and S3Table S2. The Conservation of Proteins Comprising Different Flagella or Type III Secretion System Subunits in Different Bacterial Species, Related to Figure 4Each row represents a single species from the STRING core genomes and each column represents one protein. The protein names are followed by the species of origin (Bacillus: *B. subtilis* proteins; EHEC: Enterohemorrhagic *E. coli* proteins; Chlamydia: *C. trachomatis* protein). The sequence similarity scores are based on the STRING database homology data. Species lacking any homolog were excluded from the analysis.Document S2. Article plus Supplemental Information
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